The chapter explores the evolving landscape of regenerative medicine for treating cartilage injuries in athletes, with a particular focus on the femur and tibia. The increasing prevalence of these injuries in high-impact sports necessitates innovative treatment strategies beyond traditional surgical interventions. Regenerative medicine offers promising avenues through stem cell therapy, growth factors, and scaffold implantation, aimed at restoring the hyaline cartilage rather than forming biomechanically inferior fibrocartilage. Recent advancements such as tissue engineering, 3D bioprinting, and nanotechnology are enhancing the precision and efficacy of these therapies, potentially improving functional outcomes and reducing recovery times. However, the field faces challenges, including integration of new tissue with existing cartilage, the high costs of treatment, and ethical concerns regarding stem cell use. Future directions may include gene editing technologies and the development of biocompatible scaffold materials that mimic the natural cartilage environment. A multidisciplinary approach involving collaboration between biologists, bioengineers, and clinicians is essential for advancing these innovative treatments and integrating them into clinical practice.